Performance analysis of Intensity Therapeutics (INTS)
Annual Return
Over the past 3 years, INTS has had an average annual return of -69.77%, underperforming the benchmark SPY, which returned +19.63% annual.
Since Jun 30, 2023, INTS has had an average annual return of -68.38%, underperforming the benchmark SPY, which returned +20.12% annual.
| 2026 | 2025 | 2024 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -57.12% | -76.70% | -79.46% | +43.79% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.90% | -16.15% | -23.15% | -11.39% | -15.71% | -6.78% | +7.27% | -57.12% | |||||
| 2025 | +25.57% | +5.88% | -15.82% | -70.14% | -19.25% | -35.38% | -9.71% | +1.72% | -13.95% | +200.98% | -45.31% | +2.69% | -76.70% |
| 2024 | -42.59% | -24.80% | +40.54% | -25.00% | +27.43% | -1.42% | -1.22% | -10.12% | -12.19% | -14.92% | -9.98% | -39.85% | -79.46% |
| 2023 | +0% | -4.03% | +0.88% | -31.20% | -23.68% | -19.12% | +249.68% | +43.79% |
Drawdown analysis of Intensity Therapeutics (INTS)
The maximum drawdown for the INTS was -98.53%, occurring on Jun 12, 2026. This drawdown has not yet recovered.
The current INTS drawdown is -98.22%.
Since Jun 30, 2023 INTS has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.53% | Dec 13, 2023 | 625 | Jun 12, 2026 | Ongoing | Ongoing | Ongoing |
| -67.50% | Jul 18, 2023 | 86 | Nov 16, 2023 | 15 | Dec 8, 2023 | 101 |
| -8.87% | Jul 3, 2023 | 7 | Jul 13, 2023 | 3 | Jul 18, 2023 | 10 |